Inventor profile of:

Peter Mack

City:

Chapel Hill, North Carolina

Country:

United States

Published Applications:

16

Last publication date:

2025-11-13

Top Assignees for applications by Peter Mack

The entities that hold a legal rights for patent applications filed by inventor Mack Peter:

Recent patent applications by Mack Peter

Peter Mack from Chapel Hill, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-13
US20250345323A1
Human necessities

LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS

#2 | 2025-06-26
US20250205196A1
Human necessities

FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY

#3 | 2025-05-22
US20250161268A1
Human necessities

FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY

#4 | 2025-05-22
US20250161267A1
Human necessities

FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY

#5 | 2023-09-14
US20230285386A1
Human necessities

IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS

#6 | 2023-09-14
US20230285359A1
Human necessities

Formulations of psilocin that have enhanced stability

#7 | 2023-07-13
US20230218532A1
Human necessities

Lyophilized orally disintegrating tablet formulations of d-lysergic acid diethylamide for therapeutic applications

#8 | 2023-04-20
US20230122949A1
Human necessities

LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS

#9 | 2023-04-06
US20230107398A1
Human necessities

IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS

#10 | 2023-03-09
US20230075847A1
Human necessities

IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS

#11 | 2023-03-02
US20230064429A1
Human necessities

IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS

#12 | 2022-11-24
US20220370413A1
Human necessities

FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY

#13 | 2022-09-08
US20220280482A1
Human necessities

FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY

#14 | 2016-05-12
US20160129440A1
Performing operations; transporting

Microfluidic structures for biomedical applications

#15 | 2015-05-07
US20150126411A1
Performing operations; transporting

Systems and method for high-throughput testing

#16 | 2010-12-23
US20100323916A1
Chemistry; metallurgy

High-throughput biological screening

InventorID:

1153137 ⎘